# GLAUKOS Corp (GKOS) FY2026 Q2 P&L / Income Statement

- Company: GLAUKOS Corp (GKOS)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001193125-26-324201
- Page: https://plicit.ai/financials/gkos/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/gkos-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 185,610,000 US dollars
- **Cost of sales**: 34,016,000 US dollars
- **Gross profit**: 151,594,000 US dollars
- **Total operating expenses**: 168,861,000 US dollars
- **Loss from operations**: negative 17,267,000 US dollars
- **Total non-operating (expense) income**: negative 454,000 US dollars
- **Loss before taxes**: negative 17,721,000 US dollars
- **Income tax provision**: 656,000 US dollars
- **Net loss**: negative 18,377,000 US dollars
- **Corneal Health - UNITED STATES**: 28,190,000 US dollars
- **Corneal Health - International**: 2,240,000 US dollars
- **Glaucoma - UNITED STATES**: 118,549,000 US dollars
- **Glaucoma - International**: 36,631,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 51,301,000 US dollars
- **Selling, general and administrative**: 116,060,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/gkos/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/gkos-fy2026-q2-revenue-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 185,610,000 US dollars
- **Cost of sales**: 34,016,000 US dollars
- **Gross profit**: 151,594,000 US dollars
- **Total operating expenses**: 168,861,000 US dollars
- **Loss from operations**: negative 17,267,000 US dollars
- **Total non-operating (expense) income**: negative 454,000 US dollars
- **Loss before taxes**: negative 17,721,000 US dollars
- **Income tax provision**: 656,000 US dollars
- **Net loss**: negative 18,377,000 US dollars
- **UNITED STATES**: 146,739,000 US dollars
- **International**: 38,871,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 51,301,000 US dollars
- **Selling, general and administrative**: 116,060,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/gkos/fy2026-q2-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/gkos-fy2026-q2-revenue-by-product-and-service-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 185,610,000 US dollars
- **Cost of sales**: 34,016,000 US dollars
- **Gross profit**: 151,594,000 US dollars
- **Total operating expenses**: 168,861,000 US dollars
- **Loss from operations**: negative 17,267,000 US dollars
- **Total non-operating (expense) income**: negative 454,000 US dollars
- **Loss before taxes**: negative 17,721,000 US dollars
- **Income tax provision**: 656,000 US dollars
- **Net loss**: negative 18,377,000 US dollars
- **Glaucoma**: 155,180,000 US dollars
- **Corneal Health**: 30,430,000 US dollars
- **Acquired in-process research and development**: 1,500,000 US dollars
- **Research and development**: 51,301,000 US dollars
- **Selling, general and administrative**: 116,060,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.